Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar;17(3):295-300.
doi: 10.1038/ejhg.2008.164. Epub 2008 Sep 10.

Decreasing uptake of predictive testing for Huntington's disease in a German centre: 12 years' experience (1993-2004)

Affiliations

Decreasing uptake of predictive testing for Huntington's disease in a German centre: 12 years' experience (1993-2004)

Christiane Bernhardt et al. Eur J Hum Genet. 2009 Mar.

Abstract

In this retrospective study, we examined changes in decision-making for and against the predictive genetic test for Huntington's disease including 478 persons at risk who had undergone genetic counselling in one centre in Germany between 1993 and 2004. At the outset of the counselling procedure the majority of subjects (71%) wanted to make use of the test, yet the actual demand of the predictive test result declined from 67 to 38% over the years. In addition, the time interval between counselling session and blood withdrawal was reduced, as determined by the counselees: in 2000-2004 the majority of persons at risk made the appointment for blood withdrawal after the shortest possible time span. Demographic factors of the cohort remained comparatively stable in the investigated time period. An association was evident between the ratio of test usage and the counselling person. These and other possible factors influencing the time flow of predictive DNA testing are discussed. Further studies are necessary to investigate whether changes of test demand rates are a general phenomenon.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Number of persons at risk (black bar) and predictive test performed (grey bars) during the period 1993–2004. χ2 test: P<0.001; χ2=23.9; d.f.=2.
Figure 2
Figure 2
(a) Interval between the counselling session during the time period 1993–1996 and the blood withdrawal. (b) Interval between the counselling session during the time period 1997–2000 and the blood withdrawal. (c) Interval between the counselling session during the time period 2001–2004 and the blood withdrawal.

Similar articles

Cited by

References

    1. Conneally PM. Huntington disease: genetics and epidemiology. Am J Hum Genet. 1984;36:506–526. - PMC - PubMed
    1. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72:971–983. - PubMed
    1. Quarrell OW, Rigby AS, Barron L, et al. Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational study. J Med Genet. 2007;44:e68. - PMC - PubMed
    1. International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea Guidelines for the molecular genetics predictive test in Huntington's disease. J Med Genet. 1994;31:555–559. - PMC - PubMed
    1. Meiser B, Dunn S. Psychological impact of genetic testing for Huntington's disease: an update of the literature. J Neurol Neurosurg Psychiatry. 2000;69:574–578. - PMC - PubMed